User profiles for Liane Dupont
 | Liane DupontScientist turned Venture capitalist @Lundbeckfonden BioCapital (2022-) Verified email at lundbeckfonden.com Cited by 1236 |
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
…, H Kakkassery, S Sinha, R Davis, L Dupont… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
Cytomegalovirus latency and reactivation: recent insights into an age old problem
Human cytomegalovirus (HCMV) infection remains a major cause of morbidity in patient
populations. In certain clinical settings, it is the reactivation of the pre‐existing latent infection in …
populations. In certain clinical settings, it is the reactivation of the pre‐existing latent infection in …
[PDF][PDF] The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr
Silencing of nuclear DNA is an essential feature of innate immune responses to invading
pathogens. Early in infection, unintegrated lentiviral cDNA accumulates in the nucleus yet …
pathogens. Early in infection, unintegrated lentiviral cDNA accumulates in the nucleus yet …
[PDF][PDF] Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B. 1.1. 7 variant
…, S Acors, H Winstone, S Pickering, RP Galao, L Dupont… - Immunity, 2021 - cell.com
Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor
ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing …
ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing …
Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter
L Dupont, L Du, M Poulter, S Choi, M McIntosh… - Journal of Biological …, 2019 - ASBMB
Human cytomegalovirus (HCMV) latency and reactivation rely on a complex interplay
between cellular differentiation, cell signaling pathways, and viral gene functions. HCMV …
between cellular differentiation, cell signaling pathways, and viral gene functions. HCMV …
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …
…, H Kakkassery, S Shubhankar, R Davis, L Dupont… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …
Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6
…, AI Smid, JS Snowden, L Dupont… - Proceedings of the …, 2019 - National Acad Sciences
Interferons (IFNs) represent an important host defense against viruses. Type I IFNs induce
JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral …
JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral …
[HTML][HTML] Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B. 1.1. 7 infections
As SARS-CoV-2 variants continue to emerge globally, a major challenge for COVID-19
vaccination is the generation of a durable antibody response with cross-neutralizing activity …
vaccination is the generation of a durable antibody response with cross-neutralizing activity …
Gene expression from unintegrated HIV-1 is restricted by the SMC5/6 complex
L Dupont - 2021 - repository.cam.ac.uk
Integration of viral DNA into the host genome is the hallmark of human immunodeficiency virus
1 (HIV-1) infections. However, in early infection, the most abundant viral DNA species are …
1 (HIV-1) infections. However, in early infection, the most abundant viral DNA species are …
